Search

Author/Creator Pappa, Keith A

1. Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study. (6th January 2020)

Authors:
van Wyk, Jean; Ajana, Faïza; Bisshop, Fiona; De Wit, Stéphane; Osiyemi, Olayemi; Portilla Sogorb, Joaquín; Routy, Jean-Pierre; Wyen, Christoph; Ait-Khaled, Mounir; Nascimento, Maria Claudia; Pappa, Keith A; Wang, Ruolan; Wright, Jonathan; Tenorio, Allan R; Wynne, Brian; Aboud, Michael; Gartland, ...
Journal:
Clinical infectious diseases
Issue:
Volume 71:Number 8(2020)
Page Start:
1920
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial . (25th January 2022)

Authors:
Osiyemi, Olayemi; De Wit, Stéphane; Ajana, Faïza; Bisshop, Fiona; Portilla, Joaquín; Routy, Jean Pierre; Wyen, Christoph; Ait-Khaled, Mounir; Leone, Peter; Pappa, Keith A; Wang, Ruolan; Wright, Jonathan; George, Nisha; Wynne, Brian; Aboud, Michael; van Wyk, Jean; Smith, Kimberly Y
Journal:
Clinical infectious diseases
Issue:
Volume 75:Number 6(2022)
Page Start:
975
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search